Mariko Honda
Minato, 1058461, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
In situ Generation of Fluoride Catalysts for CO2-to-Formic Acid Conversion With Silicon Reducing Agent.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: April 01, 2026
Real-world persistence of vibegron in patients aged ≥ 80 years with overactive bladder: a multicenter cohort study.
Journal: World journal of urology
Published: February 01, 2026
Effect of immobilized amine structure on the formation and catalysis of Pd nanoparticles for oxidation of alcohols.
Journal: Chemical communications (Cambridge, England)
Published: January 12, 2026
Pathological diagnosis and therapeutic management of hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma.
Journal: International cancer conference journal
Published: July 19, 2025
Silica-Immobilized Pd-Amine Catalysts for Suzuki-Miyaura Coupling with Catalytic Amounts of Base.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: April 18, 2025
UPFRONT DOCETAXEL WITH ANDROGEN DEPRIVATION THERAPY IN MALES WITH HIGH-VOLUME METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: RESULTS OF A SINGLE-INSTITUTION SERIES
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 19, 2025
Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: "Do we still need levofloxacin? ".
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: September 05, 2024
Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate.
Journal: JAMA network open
Published: March 15, 2024
Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy.
Journal: International journal of clinical oncology
Published: October 09, 2023
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis.
Journal: Clinical genitourinary cancer
Published: August 17, 2023
Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer.
Journal: Anticancer research
Published: April 20, 2023
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 13, 2023
Last Updated: 09/26/2026